Results 311 to 320 of about 897,135 (405)
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai +4 more
wiley +1 more source
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo +10 more
wiley +1 more source
Door-to-Balloon Time Delay in Complex Primary Angioplasty: A Case of Anomalous Origin of the Right Coronary Artery From the Pulmonary Artery (ARCAPA). [PDF]
Montefusco G +9 more
europepmc +1 more source
Exploring the role of apolipoprotein ε4 in progressive myoclonic epilepsy type 1
Abstract Objective Progressive myoclonic epilepsy type 1 (EPM1) is a neurodegenerative disease caused by biallelic variants in the cystatin B (CSTB) gene. Despite a progressive course, phenotype severity varies among patients, even within families. We studied the potential role of APOE ε4 in modifying phenotypic diversity in EPM1, given its established
Janina Gunnar +10 more
wiley +1 more source
Right coronary artery-right ventricle fistula with a rare giant thrombotic aneurysm: a case report and literature review. [PDF]
Chen X, Wang X, Yu J, Pan J.
europepmc +1 more source
Abstract Objective Late‐onset unexplained epilepsy (LoUE), defined as epilepsy onset after age 55 without an obvious cause, is an important risk factor for dementia. Studies have shown that 10%–25% of individuals with LoUE develop dementia within 3–4 years following their first seizure.
Alice D. Lam +13 more
wiley +1 more source
A thrombus detachment from the right coronary artery ostium caused cerebral infarction after coronary artery angiography: A case report. [PDF]
Fang L.
europepmc +1 more source
Coronary artery-right atrium fistula.
RUSSO, Maria Giovanna +4 more
openaire +2 more sources
Whey protein‐based microencapsulation for omega‐3 PUFA delivery in food systems. Objective: Enhance oxidative stability & bioavailability of omega‐3 PUFAs using whey protein as an encapsulating agent. Current methods: Spray drying & coacervation—effective but limited by heat sensitivity and encapsulation efficiency. Emerging technologies: Electrospray &
Jihan M. Kassem +9 more
wiley +1 more source

